A consultation fee applies for the first visit and for any new itinerary
The virus causes chickenpox during the first infection and can later lead to shingles.
In adults, the vaccine is used to prevent shingles, and it is especially recommended for those aged 50 and older.
A quadrivalent vaccine targeting the expected circulating strains.
The vaccine prevents tetanus infection in case of injury. It is particularly important for older adults, who are more susceptible to tetanus.
The standard schedule consists of three doses: at the initial visit, 1 month later, and 1 year later. The protection lasts for approximately 10 years.
Learn more about the Tetanus Toxoid here.
The Measles and Rubella (MR) Vaccine is recommended for everyone who has not completed the two-dose series.
Although outbreaks occasionally occur domestically, vaccination is recommended worldwide even for short-term travel abroad.
(Prices revised as of July 1, 2024)
Learn more about the Measles and Rubella (MR) Vaccine here.
This vaccine prevents infection by the viruses associated with cervical cancer, its precancerous lesions, vulvar intraepithelial neoplasia, vaginal intraepithelial neoplasia, and genital warts. It is indicated for females aged 9 to 45 years, and three doses over six months are required.
Learn more about the Cervical Cancer Vaccine here
Learn more about the 9-valent cervical cancer vaccine “Cervarix 9” here
| [Domestic] Gardasil 4 (Cervical Cancer Vaccine) | ¥20,500 (¥22,550 tax included) |
|---|---|
| [Domestic] Cervarix 9 (Cervical Cancer Vaccine) | ¥29,500 (¥32,450 tax included) |
This vaccine prevents severe pneumonia. Depending on your municipality, some doses may be available free of charge. Please contact your local government office in advance to confirm eligibility.
If using public funding, please bring the necessary documents. For those aged 65 and older, a booster every 5 years is recommended.
| Neumovax NP Syringe (23-valent) | ¥11,500 (¥12,650 tax included) |
|---|---|
| Prevnar 20 (20-valent, aqueous suspension) | ¥15,500 (¥17,050 tax included) |
| BacnuVance (15-valent, aqueous suspension syringe) | ¥15,500 (¥17,050 tax included) |
A vaccine to prevent shingles (caused by the Varicella Zoster Virus) has recently been approved in Japan.
Compared to the previously used varicella (chickenpox) vaccine, this vaccine offers much higher preventive efficacy and is becoming the global standard. It is indicated for individuals aged 50 and older, and two doses over six months are required.
